Leadership transition With a planned leadership transition in 2026, including a new CEO and an Executive Chairman, there is an opportunity to engage in executive-level conversations about strategic priorities, potential partnerships, and ongoing investments in sterilization, lab testing, and advisory services to align with the new leadership's vision.

Growth leverage Sotera Health operates across 63 facilities in 13 countries with a diversified portfolio (sterilization, lab testing, isotopes). This presents a cross-sell opportunity to expand contracts with existing customers by bundling sterilization, testing, and advisory services for medical devices, pharma, tissue, and food industry clients.

Sustainability focus The company emphasizes employee safety, environmental responsibility, and sustainability principles, signaling a potential fit for services and solutions around environmental compliance, energy efficiency, and sustainable packaging or waste reduction initiatives for healthcare operations.

Industry positioning As a leading global provider with historic credibility in sterilization, gamma technologies, and extractables/leachables testing, Sotera Health is well positioned to win large integrated sterilization and testing projects; identify prospects among healthcare device manufacturers and pharma firms seeking end-to-end quality assurance.

Knowledge workforce With a global team including hundreds of scientists and a substantial R&D footprint, there are opportunities to offer value-added services such as advanced analytics, ongoing compliance testing, and customized QA programs to deepen relationships with existing customers and attract new ones seeking rigorous scientific partnerships.